Inventor · disambiguated record
Jürgen Herbert Ernst Kuball
Also filed as: KUBALL JUERGEN HERBERT ERNST · KUBALL JURGEN HERBERT ERNST · KUBALL JÜRGEN HERBERT ERNST
9 granted patents·4 pending applications·13 citations·filing 2013–2024
82Inventor score
Top patents by PatentIndex Score
13 records- 0184US9891211B2Gamma 9 delta 2 T cell receptorsUMC UTRECHT HOLDING BV·Filed 2013·Granted Feb 13, 2018·8 cites·19 claims
- 0279US10324083B2Methods of treating cancer in a subject by administering a composition comprising gamma 9 delta 2 T-cell receptorsGADETA B V·Filed 2017·Granted Jun 18, 2019·3 cites·32 claims
- 0378US2025043010A1Method for identifying deltaT-cell (or gammaT-cell) receptor chains or parts thereof that mediate an anti-tumour or an anti-infective responseUMC UTRECHT HOLDING BV·Filed 2024·Application pending·0 cites
- 0476US10578609B2Nucleic acid molecules encoding combinatorial gamma 9 delta 2 T-cell receptors and methods of use thereof to treat cancerGADETA B V·Filed 2016·Granted Mar 3, 2020·2 cites·20 claims
- 0569US2023248770A1Human leukocyte antigen restricted gamma delta t cell receptors and methods of use thereofGADETA B V·Filed 2023·Application pending·0 cites
- 0666US12297274B2Method of cell therapyUMC UTRECHT HOLDING BV·Filed 2020·Granted May 13, 2025·0 cites·13 claims
- 0762US11686724B2Compositions comprising gamma 9 delta 2 T-cell receptors and methods of use thereof to treat cancerGADETA B V·Filed 2020·Granted Jun 27, 2023·0 cites·22 claims
- 0862US11166984B2Method for identifying δT-cell (or γT-cell) receptor chains or parts thereof that mediate an anti-tumour or an anti-infective responseUMC UTRECHT HOLDING BV·Filed 2018·Granted Nov 9, 2021·0 cites·17 claims
- 0961US11596654B2Human leukocyte antigen restricted gamma delta T cell receptors and methods of use thereofGADETA B V·Filed 2018·Granted Mar 7, 2023·0 cites·9 claims
- 1059US2019271688A1Methods of treating cancer in a subject by administering a composition comprising gamma 9 delta 2 t-cell receptorsGADETA B V·Filed 2019·Application pending·0 cites
- 1148US12161669B2Compositions and methods for cell targeting therapiesUMC UTRECHT HOLDING BV·Filed 2018·Granted Dec 10, 2024·0 cites·8 claims
- 1243US2022193137A1Modified immune receptor constructsUMC UTRECHT HOLDING BV·Filed 2020·Application pending·0 cites
- 1342US10973895B2Use of antibodies for enrichment of engineered T cells with exogenous immune receptors and antibodies for use in depletion of engineered T cellsUMC UTRECHT HOLDING BV·Filed 2015·Granted Apr 13, 2021·0 cites·4 claims
Join the waitlist — get patent alerts
Get an alert when Jürgen Herbert Ernst Kuball files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →